Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Page Not Found
Cart summary

You have no items in your shopping cart.

Concanavalin A

SKU: orb1303318

Description

Concanavalin A is a plant lectin with glycan-binding properties, studied for its antitumor effects in vitro and in vivo. It is also a well-documented model agent for investigating immune-mediated acute liver injury in experimental research settings.

Research Area

Cell Biology, Infectious Disease & Virology

Images & Validation

−

Key Properties

−
CAS Number11028-71-0
MW104-112 kDa
FormulaC23H32N6O8S
SMILESCCCN(CCC)S(=O)(=O)c1ccc(cc1)C(O)=O.Cc1cn(C2CC(N=[N+]=[N-])C(CO)O2)c(=O)[nH]c1=O
TargetAntibiotic,Apoptosis
SolubilityH2O:soluble;PBS:5 mg/mL

Bioactivity

−
Target IC50
ML-1 cells:10 μg/mL|CT-26 cells:10 μg/mL|HIV-1:2.2–2.6 μg/mL (EC50)|HSV:98 nM|HepG2 cells:5 μg/mL|MCF-7 cells:15 μg/mL|Huh7 cells:20 μg/mL
In Vivo
METHODS: To assay antitumor activity in vivo, Concanavalin A (10 mg/kg, intravenously) and ISO-1 (10 mg/kg, intraperitonealy) were administered to BALB/c mice bearing ML-1 liver tumor nodules twice every three days for 30 days. RESULTS: Concanavalin A treatment significantly reduced the number and size of hepatic tumor nodules and, in the presence of ISO-1, the therapeutic effect of Concanavalin A was abolished. MIF does play an important role in Concanavalin A-induced autophagy and antitumor activity in vivo.
In Vitro
METHODS: Human hepatocellular carcinoma cells HuH-7 and Hep G2 were treated with Concanavalin A (1-40 µM) for 3-48 h, and the expression levels of target proteins were detected by Western Blot. RESULTS: After Concanavalin A stimulation, LC3-II in both human hepatocellular carcinoma cell lines increased in a dose- and time-dependent manner. METHODS: HUVECs and EA.hy926 cells were treated with Concanavalin A (0.3-1 µg/mL) for 6-24 h. The pro-angiogenic activity was detected by Matrigel tube formation and ELISA assay. RESULTS: Different concentrations of Concanavalin A, especially at 1 or 3 µg/mL, significantly promoted angiogenesis in HUVEC and Ea.hy926 cells. The total primary fragment length in HUVEC and Ea.hy926 cells was significantly higher in Concanavalin A-treated cells compared to the negative control.

Storage & Handling

−
Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

−
Antibiotic, Apoptosis, Concanavalin A, jack bean, inhibit, glucose, Inhibitor, mannose, plant lectin, programmed cell death

Similar Products

−
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

−
No computed properties available.

Protocol Information

Available Sizes

Select a size below

10 mg
$ 70.00
25 mg
$ 90.00
50 mg
$ 100.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry